0001628280-20-004839.txt : 20200409 0001628280-20-004839.hdr.sgml : 20200409 20200409144650 ACCESSION NUMBER: 0001628280-20-004839 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200408 FILED AS OF DATE: 20200409 DATE AS OF CHANGE: 20200409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strauss David Eric CENTRAL INDEX KEY: 0001799869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 20784071 MAIL ADDRESS: STREET 1: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_158645799377226.xml FORM 4 X0306 4 2020-04-08 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001799869 Strauss David Eric C/O BELLICUM PHARMACEUTICALS, INC. 611 GATEWAY BLVD., SUITE 820 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Director, Corporate Controller Restricted Stock Units 2020-04-08 4 A 0 6984 0 A Common Stock 6984.0 6984 D Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in full on April 8, 2021. /s/ David E. Strauss 2020-04-09